Arteris (NASDAQ:AIP) CFO Nicholas Hawkins Sells 3,660 Shares

Key Points

• Arteris CFO Nicholas Hawkins sold 3,660 shares at an average price of $8.69, totaling approximately $31,805, and now owns 103,898 shares valued at around $902,873.
• The company's stock has a market capitalization of $369.35 million and a current price-to-earnings ratio of -10.56.
• Three analysts have rated Arteris with a Buy rating and the stock has an average price target of $15.00.

Arteris, Inc. (NASDAQ:AIP - Get Free Report) CFO Nicholas Hawkins sold 3,660 shares of the stock in a transaction dated Tuesday, September 9th. The shares were sold at an average price of $8.69, for a total transaction of $31,805.40. Following the transaction, the chief financial officer owned 103,898 shares of the company's stock, valued at approximately $902,873.62. The trade was a 3.40% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Arteris Stock Performance

NASDAQ AIP traded down $0.06 during trading on Wednesday, hitting $8.66. 663,098 shares of the company's stock traded hands, compared to its average volume of 550,932. The stock has a market capitalization of $369.35 million, a price-to-earnings ratio of -10.56 and a beta of 1.44. Arteris, Inc. has a 12-month low of $5.46 and a 12-month high of $14.29. The business has a 50 day moving average of $9.50 and a 200-day moving average of $8.22.

Arteris (NASDAQ:AIP - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported ($0.11) EPS for the quarter, meeting the consensus estimate of ($0.11). The business had revenue of $16.50 million for the quarter, compared to the consensus estimate of $16.35 million. Arteris had a negative net margin of 52.41% and a negative return on equity of 8,546.17%. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. On average, analysts expect that Arteris, Inc. will post -0.73 EPS for the current year.

Institutional Investors Weigh In On Arteris

Hedge funds and other institutional investors have recently made changes to their positions in the business. Raymond James Financial Inc. purchased a new stake in Arteris in the 2nd quarter worth approximately $32,000. CWM LLC boosted its position in shares of Arteris by 4,810.1% during the 1st quarter. CWM LLC now owns 10,213 shares of the company's stock valued at $71,000 after acquiring an additional 10,005 shares during the last quarter. Cambridge Investment Research Advisors Inc. bought a new position in shares of Arteris during the 1st quarter valued at approximately $95,000. Savant Capital LLC bought a new position in shares of Arteris during the 2nd quarter valued at approximately $97,000. Finally, Kapitalo Investimentos Ltda purchased a new stake in Arteris during the 2nd quarter valued at $104,000. Hedge funds and other institutional investors own 64.36% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on AIP shares. Rosenblatt Securities reissued a "buy" rating and issued a $14.00 price target on shares of Arteris in a report on Wednesday, May 21st. TD Cowen increased their price target on shares of Arteris from $12.00 to $15.00 and gave the stock a "buy" rating in a report on Wednesday, August 6th. Finally, Wall Street Zen downgraded shares of Arteris from a "hold" rating to a "sell" rating in a report on Sunday. Three analysts have rated the stock with a Buy rating, According to MarketBeat.com, Arteris currently has an average rating of "Buy" and an average target price of $15.00.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.